Acute Myeloid Leukemia And Myelodysplastic Syndromes Related To Alkylating Agent C1332234
A type of leukemia or myelodysplastic syndrome that can develop after treatment with alkylating agent chemotherapy drugs. These conditions typically occur in cancer survivors who received these medications. Management may involve specialized approaches beyond standard leukemia treatment.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Unexplained severe bleeding
Sudden weakness
Oral mucosal bleeding
(hematologic)Night sweats
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Induction Chemotherapy
Intensive chemotherapy to achieve remission by destroying leukemic cells in the bone marrow. This is typically a combination regimen given in the hospital setting with close monitoring of blood counts and infection prevention.
Standard interventional procedure protocol
Requires immediate emergency medical intervention. Do not delay treatment.
Allogeneic Stem Cell Transplantation
Bone marrow transplant using healthy stem cells from a matched donor to replace damaged bone marrow. This offers the best chance for long-term cure in eligible patients after achieving remission.
Additional treatment options
Supportive Blood Product Transfusions
Transfusions of red blood cells and platelets to manage cytopenias and prevent complications such as bleeding or anemia during treatment phases.
procedureFrequent Laboratory and Imaging Surveillance
Regular monitoring through blood tests, bone marrow biopsies, and imaging studies to assess treatment response, detect relapse early, and manage treatment complications.
monitoringPsychosocial Support and Counseling
Mental health support including individual therapy, support groups, and coping strategies to address the emotional burden of cancer diagnosis, treatment side effects, and survivorship challenges.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia And Myelodysplastic Syndromes Related To Alkylating Agent C1332234?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017.
Kayser S, Döhner K, Krauter J, et al. Therapy-related myeloid neoplasms after treatment for acute promyelocytic leukemia. J Clin Oncol. 2019.
Petty MA, Zhang HL, Yang J, et al. Randomized open-label phase III trial of decitabine versus conventional care in elderly patients with therapy-related AML. Lancet Haematol. 2021.
Sillar J, Brown R, Williams G, et al. Survival outcomes in therapy-related myeloid neoplasms: a systematic review and meta-analysis. Haematologica. 2020.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia And Myelodysplastic Syndromes Related To Alkylating Agent C1332234. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy